CClinicalTrials.gg
TerminatedNCT03178175Updated Mar 1, 2019

Acupuncture for Management of Balance Impairment in Patients With Parkinson's Disease

An interventional study of Acupuncture and Needle Insertion in Parkinson Disease and Acupuncture, sponsored by Chang Bing Show Chwan Memorial Hospital. Terminated at 1 site in Taiwan. Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-03-01.

Sponsored by Chang Bing Show Chwan Memorial Hospital · Not applicable, Interventional, and Treatment

Why this study was terminated
This study will be terminated due to poor patient recruitments.

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Dec 2016, registered May 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
50 Years to 75 Years
Sex
All
01

Study summary

This plan is to evaluate the effectiveness of scalp acupuncture, a modern acupuncture technique specialized to neurological disorders, in managing motor function and body balance for PD patients. This is a randomized, controlled, single-blind clinical trial.

Read the detailed description

BACKGROUND: Parkinson's disease (PD) is an age-related progressive neurodegenerative disease. The etiology and pathogenetic mechanisms that cause PD are still not fully understood. Scalp acupuncture (SA), a common treatment modality within complementary and alternative medicine, has been widely used for PD.

OBJECTIVE: To evaluate the effectiveness of scalp acupuncture, a modern acupuncture technique specialized to neurological disorders, in managing motor function and body balance for PD patients.

DESIGN: Randomized, controlled, single-blind clinical trial. SETTING: Department of Neurology, Chang Bing Show Chwan Memorial Hospital in Changhua County.

PARTICIPANTS: Patients with PD of grade 1 to 3 of Hoehn \& Yahr (H\&Y) scale (N = 26).

INTERVENTIONS: SA group (Si Shen Cong and Baihui) or control group. The techniques were administered by traditional chinese medicine trained in SA and evaluated at baseline and at 20 and 30 minutes.

MAIN OUTCOME MEASURE: Motor score subscale of Unified Parkinson's Disease Rating Scale (UPDRS) was used to measure the motor performances. Balance ability in each patient was assessed as follows: subjects were placed on a force platform (SPS, SYNAPSYS posturography system) to assess the displacement area from the centre of gravity, either with eyes open or closed, in a standing posture. The mini balance evaluation systems test (the mini-BESTest) was used to measure the performance of balance and walking speed. The test was repeated twice each in baseline period, SA period and post-SA period. The Mann-Whitney U test, Chi-square test, and Fisher's exact test were used to compare the baseline characteristics of the 2 groups. One-way repeated measures ANOVA was used to examine the differences among different time points (before, during, and after acupuncture treatment) within a group. Association between continuous variables was evaluated with Spearman's rank correlation coefficient.

02

Conditions studied

  • Parkinson Disease
  • Acupuncture

Browse trials for

Keywords

  • Scalp acupuncture
  • Parkinson's disease
  • Balance
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 4 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Chang Bing Show Chwan Memorial Hospital is the lead sponsor of 11 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 50-75
  • Meet the diagnostic criteria of Parkinson's disease: UK (United Kingdom) Parkinson's disease society brain bank clinical diagnostic criteria
  • Disease severity of Hoehn-Yahr stage: stage I to III
  • clinical condition stable, not adjusting medicine in recent 3 months
  • no falling episode in recent 1 year
  • live independently

Exclusion criteria

Exclusion Criteria:

  • already enrolled in another studies
  • can't cooperate this evaluation examinations due to poor visual acuity, impaired cognitive function, musculoskeletal system disorder, or psychiatric illness
  • any other condition would make participants not to cooperative this study
  • can't tolerate acupuncture procedure
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
4 participants (actual)

Study arms

  • Experimental
    acupuncture with "De Qi"

    all participants in this group will receive the standard procedure of acupuncture.

    Procedure: Acupuncture

  • Sham comparator
    Sham acupuncture

    In this group, all participants will receive acupuncture needle insertion but not exact acupoint's location and depth.

    Procedure: Needle Insertion

Interventions

  • ProcedureAcupuncture

    In the acupuncture with "De Qi" group, using stainless tiny needles is inserted to the specific acupoints over the scalp (Si Shen Cong and Baihui) until the "De Qi" phenomenon occurs. The duration is about 30 minutes, and all patients will receive the procedure 16 times within 2 months.

  • ProcedureNeedle Insertion

    In the Sham acupuncture group, using stainless tiny needles is inserted to the specific acupoints over the scalp (Si Shen Cong and Baihui) but the needle doesn't reach the exact depth and "De Qi" phenomena doesn't occur. The duration is about 30 minutes, and all patients will receive this procedure 16 times within 2 months.

06

What researchers measure

Primary outcomes

  1. Balance function evaluation

    check participants' balance function by mini-BESTest (mini-Balance Evaluation Systems Test)

    Time frame: 15-20 minutes

Secondary outcomes

  1. Motor function evaluation

    check participant's motor function by UPDRS (Unified Parkinson's Disease Rating Score)

    Time frame: 15-20 minutes

07

Study locations

1 site
  • Chang Bing Show Chwan Memorial Hospital
    Chang-hua, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03178175
Lead sponsor
Chang Bing Show Chwan Memorial Hospital
Responsible party
Sponsor
First posted
Jun 6, 2017
Start date
Dec 29, 2016
Primary completion
Dec 1, 2018
Completion
Dec 11, 2018
Last update
Mar 1, 2019

Study contacts

Chao Hsien Hung, M.D.
principal investigator · Chang Bing Show Chang Memorial Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion